Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.
about
12-month intravascular ultrasound observations from BiOSS® first-in-man studiesBiOSS LIM C: thin-strut cobalt-chromium version of the dedicated bifurcation stent.Assessment of vascular response to BiOSS LIM C® stents vs Orsiro® stents in the porcine coronary artery model.Mehran in-stent restenosis classification adapted for coronary bifurcations: the impact on 4-year follow-up from randomized clinical studies POLBOS I and II
P2860
Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@en
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@nl
type
label
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@en
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@nl
prefLabel
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@en
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@nl
P2093
P50
P1476
Regular Drug-Eluting Stent vs ...... zed Controlled POLBOS I Trial.
@en
P2093
Radoslaw Formuszewicz
Sławomir Dobrzycki
Vladimír Džavík
P304
P356
10.1016/J.CJCA.2014.12.024
P577
2014-12-24T00:00:00Z